General description
Medicine type
Biological agent
EML status history
First added in 2023
(TRS
1049)
for
Coagulation defects, purpura or other haemorrhagic or related conditions
Added in 2023
(TRS
1049)
for
Von Willebrand disease
Added in 2023
(TRS
1049)
for
Obstetric haemorrhage
Added in 2023
(TRS
1049)
for
Haemophilia A
Therapeutic equivalent for
cryoprecipitate (pathogen-reduced)
for
Haemophilia A
cryoprecipitate (pathogen-reduced) for Obstetric haemorrhage, unspecified
cryoprecipitate (pathogen-reduced) for Von Willebrand disease
cryoprecipitate (pathogen-reduced) for Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
cryoprecipitate (pathogen-reduced) for Obstetric haemorrhage, unspecified
cryoprecipitate (pathogen-reduced) for Von Willebrand disease
cryoprecipitate (pathogen-reduced) for Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
Wikipedia